The research team, led by Seung-Bo Park and Junggi Hong of CHA University’s Graduate School of Sports Medicine, recruited 14 adults with type 2 diabetes and asked each of them to complete three separate walking sessions. In one condition, participants walked normally with no robotic assistance. In the other two, they wore the Bot-Fit wearable hip exoskeleton, a Samsung Electronics-developed device that attaches around the hips and thighs and uses motorized assistance or resistance at the hip joints to alter how hard the muscles must work during each stride. The two robotic modes, called Aqua and Boost, were designed to impose different physiological demands.

The experimental design was deliberately rigorous for a proof-of-concept study. Because glucose responses vary widely from person to person and from day to day, the investigators used a randomized, partially counterbalanced crossover protocol, meaning every participant experienced all three walking conditions, with the order shuffled to cancel out carryover effects. Walking intensity was individualized by setting each person’s pace to elicit 40 percent of their heart rate reserve, a measure that accounts for resting and maximum heart rate, and that target was held constant across all three conditions. This ensured that any differences in blood sugar outcomes could be attributed to the robotic mode rather than to one group simply exercising harder.

Glucose was tracked with capillary blood samples taken at baseline and then every 10 minutes for a full 120 minutes after the walk began, allowing the team to construct a fine-grained picture of the post-meal glucose curve. Alongside the metabolic measurements, the researchers recorded heart rate, blood lactate concentrations, and each participant’s rating of perceived exertion, the subjective sense of how hard the effort felt. These secondary measures were critical to the study’s central question: whether robotic modes could change not just the glucose outcome but the physiological cost of achieving it.

The headline result was unambiguous. Compared with unassisted walking, both robotic modes significantly reduced total and incremental glucose exposure, mean blood glucose, peak glucose, and the magnitude of the glucose spike, all at statistical significance. The incremental area under the glucose curve, a standard summary of how much excess glucose circulates over time, fell from 6461 plus or minus 2477 mg·min/dL during unassisted walking to 4877 plus or minus 1946 under the Aqua mode and 5072 plus or minus 2339 under Boost, a reduction the authors report at P less than .001. For a population in which post-meal glucose excursions drive both daily symptom burden and long-term cardiovascular risk, a difference of that size from a single 30-minute walk is striking.

The two robotic modes, however, were not interchangeable, and the differences between them reveal an interesting physiological trade-off. The Aqua mode, which combines robotic assistance with elements of resistance, produced the strongest glycemic profile: it further reduced early glucose exposure and glucose variability compared with unassisted walking. But it came at a price. Mean heart rate during Aqua walking was 118.9 plus or minus 20.2 beats per minute, significantly higher than the 105.7 plus or minus 16.3 beats per minute recorded during unassisted walking, and peak blood lactate was also elevated, indicating greater metabolic strain.

The Boost mode told a different story. It delivered a glycemic benefit comparable to Aqua on the primary endpoints while keeping mean heart rate at 101.3 plus or minus 13.9 beats per minute, essentially indistinguishable from unassisted walking. More remarkably, participants rated the effort substantially lower: a perceived exertion score of 4.0 plus or minus 1.3 versus 5.2 plus or minus 2.3 for the unassisted condition, a difference that reached statistical significance. In other words, Boost allowed walkers to achieve better glucose control while feeling as though they were working less hard, a combination that could matter enormously for adherence in a disease where exercise prescriptions are notoriously difficult to sustain.

The mechanistic logic behind these findings rests on how hip-joint robotics reshape muscle recruitment during gait. Walking clears glucose from the bloodstream primarily through contraction-mediated uptake in the leg muscles, a pathway that operates partly independently of insulin and is therefore especially valuable in type 2 diabetes, where insulin resistance blunts the normal hormonal route. By assisting or resisting hip flexion and extension, the exoskeleton alters the pattern and intensity of muscle activation across the large muscle groups of the lower body. The Aqua mode’s higher heart rate and lactate values suggest it recruited more total muscle mass or drove greater metabolic turnover, plausibly explaining its superior effect on early glucose disposal and curve variability. Boost’s lower perceived exertion at equal heart rate suggests the device offloaded mechanical work from the walker, reducing the subjective cost of the same cardiovascular effort.

The study’s authors are careful to frame the work as an acute, proof-of-concept experiment rather than a demonstration of clinical benefit. Fourteen participants, a single post-meal session per condition, and no long-term follow-up leave open the most important questions: whether the glycemic advantage persists with repeated use, whether it translates into improvements in glycated hemoglobin or insulin sensitivity over weeks and months, and whether older adults or those with diabetic complications can tolerate the devices safely. The trial was retrospectively registered on ClinicalTrials.gov, and the funding came from Samsung Electronics, the device’s manufacturer, though the company reports no role in study design, data analysis, or the decision to publish, and the authors declare no other competing interests.

Even with those caveats, the findings point toward an intriguing convergence of rehabilitation robotics and metabolic medicine. Wearable exoskeletons have largely been developed for gait rehabilitation after stroke or spinal cord injury, and for industrial workers seeking to reduce fatigue. This study suggests a third application: precision tuning of a everyday behavior, the post-meal walk, that millions of people with diabetes are already told to perform. If larger trials confirm that robotic modes can deliver stronger glucose control at lower perceived effort, the postprandial walk could evolve from generic advice into a tunable, quantifiable intervention, with the mode selected to match an individual’s fitness, preferences, and glycemic profile. For now, the message from Seongnam is a tantalizing preview: the humble walk after dinner may have untapped potential, and a motor at the hip might be the key to unlocking it.

Subject of Research: Effects of wearable hip exoskeleton-assisted postprandial walking on glycemic responses in adults with type 2 diabetes

Article Title: Effects of wearable hip exoskeleton-assisted postprandial walking on glycemic responses in patients with type 2 diabetes: a randomized crossover study

Article References: Park, S.-B., Yang, G., & Hong, J. (2026). Effects of wearable hip exoskeleton-assisted postprandial walking on glycemic responses in patients with type 2 diabetes: a randomized crossover study. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-026-02519-0

Image Credits: AI Generated

DOI: 10.1186/s12902-026-02519-0

Keywords: type 2 diabetes, wearable robot, hip exoskeleton, postprandial glucose, glycemic response, exercise, blood lactate, perceived exertion, crossover trial, glucose variability, heart rate reserve, Bot-Fit

The trial, conducted with 18 healthy Japanese men aged 20 to 60, was designed to answer a deceptively simple question: could the physical structure imparted by extrusion processing change the way the body handles the sugars and fats in chocolate? Extrusion cooking is an industrial workhorse technique in which ingredients are continuously mixed, kneaded, heated, and pressurized as they pass through a screw-driven barrel. It is prized for its versatility, low cost, and speed, and it is already used to produce countless snacks and breakfast cereals. Previous research had shown that extrusion can gelatinize starch and alter how lipids are extracted from cereal matrices, but no study had yet examined whether the technique could reshape the digestive fate of sugar in a confectionery product.

To find out, the team prepared two chocolates that were, on paper, twins. Both contained 33.55 percent sugar, 6.6 percent cocoa mass, skim milk powder, cocoa butter equivalent, and lecithin, with the balance made up of whole milk powder. The only difference lay in the pre-treatment: in the extruded version, the sugar, cocoa mass, and a portion of the whole milk powder were first run through a laboratory-scale twin-screw extruder, with barrel zones ranging from 20 to 95 degrees Celsius, a screw speed of 200 revolutions per minute, and a controlled moisture environment, before being ground and incorporated into the final chocolate. Nutrient analysis confirmed that protein, fat, cholesterol, sucrose, lactose, starch, and dietary fiber contents were essentially indistinguishable between the two samples, meaning any differences in the body’s response could be attributed to processing rather than composition.

Each participant consumed 76 grams of chocolate—20 small pieces—within five minutes after a 12-hour fast, on two separate study days separated by a washout period of at least one week. Blood samples were drawn at seven time points over three hours, and levels of glucose, insulin, and triglycerides were measured using enzymatic assays and chemiluminescence immunoassay. Participants also completed visual analog scale questionnaires rating their hunger, fullness, and desire to eat at intervals throughout the session. The crossover design meant that every man served as his own control, neutralizing the individual metabolic variation that often clouds nutrition studies.

The results were striking in their specificity. Fasting baseline values for glucose, insulin, and triglycerides were statistically identical before each treatment, yet the postprandial trajectories diverged. Blood glucose rose less steeply after the extruded chocolate: at 45 minutes, the increment was 17.8 milligrams per deciliter above baseline for the extruded sample compared with 25.1 for the conventional one. Insulin told an even clearer story. At 30 minutes, insulin levels were significantly lower after the extruded chocolate, and the incremental area under the insulin curve—a measure of total hormone exposure over time—was significantly reduced at every checkpoint from 30 through 120 minutes, with p-values ranging from 0.006 to 0.040. Serum triglycerides, which climbed steadily for the full three hours after either chocolate, were significantly lower at 30 and 45 minutes following the extruded version.

Why would an invisible processing change ripple through metabolism this way? The researchers turned to an in vitro model of the early digestive tract to find out. They incubated melted samples of both chocolates in a simulated gastric dissolving solution, adapted from a standardized digestion protocol and held at body temperature, then measured how much sucrose and lactose leached into the surrounding fluid over 5, 15, and 30 minutes. Sucrose was quantified as a sucrose equivalent—the combined molarity of sucrose and the glucose released as it hydrolyzed—using high-performance liquid chromatography with a refractive index detector and an amino column. The answer was consistent: the extruded chocolate released less sugar into solution at every time point, with the sucrose equivalent significantly lower at 5 and 15 minutes. Slower dissolution, the authors reason, likely translates into slower digestion and a gentler glycemic rise in the gut.

This mechanism fits neatly into a broader body of evidence on food structure and bioavailability. Carbohydrate bioavailability is known to depend not only on the chemical identity of nutrients but on their physical form—the size of voids within the food matrix, the viscosity of the digestive fluid, and the barriers that form between nutrients and digestive enzymes. Prior work has shown that extrusion can create dense networks that bind water and increase viscosity, slowing the release of glucose, and that food structuring generally strengthens barrier properties within a matrix. In pharmaceutical science, the opposite goal—accelerating dissolution to improve drug bioavailability—is a major research enterprise, underscoring just how powerful dissolution kinetics can be. The chocolate study suggests confectionery manufacturers could deliberately exploit the same physics in reverse, slowing sugar release without altering taste or ingredient lists.

There was also a satiety dividend. Questionnaire data showed that eating chocolate of either kind reduced hunger and the desire to eat, but fullness scores at 120 minutes were significantly higher after the extruded chocolate. The authors note that delayed sugar absorption is known to prolong satiety, and that insulin itself contributes to satiety signaling through leptin secretion, though the precise mechanism linking the blunted metabolic response to sustained fullness remains unresolved. They frame the finding in terms of food well-being—an emerging paradigm that moves beyond restraint and restriction toward enjoying palatable foods engineered to support health. Because the extruded chocolate tasted and weighed the same as its conventional counterpart, consumers would not need to sacrifice pleasure to blunt the metabolic cost of an indulgence.

The study is not without caveats, and the authors are candid about them. All participants were men, most of them middle-aged, so the findings cannot yet be generalized to women or to younger or older populations. The acute metabolic differences, while statistically significant, were modest in absolute terms, and their cumulative effect on people who eat chocolate regularly remains to be tested in longer-term trials. The researchers also did not measure GLP-1, the gut hormone central to current debates about appetite and metabolism, although their in vitro dissolution work provides a plausible mechanistic bridge. Funding and authorship disclosures note that most of the research team are employees of Morinaga & Co. Ltd., which supplied the research expenses and test samples, a common arrangement in food industry science that readers should weigh alongside the study’s rigorous crossover design and registered protocol.

Even with those limitations, the trial makes a genuinely novel contribution: it is, to the authors’ knowledge, the first human evidence that extrusion processing can alter the postprandial metabolic response to sugar in a real food. The implications stretch well beyond chocolate. If the same structuring principles can be applied to other sugar-rich products—baked goods, cereals, confections—food engineers may gain a new lever for managing glycemic and lipidemic responses at the population level, one that requires no reformulation, no sweetener substitution, and no change in portion size. In an era when glucose spikes are increasingly linked to endothelial damage, oxidative stress, and cardiovascular risk, the idea that a factory screw press could quietly soften the metabolic impact of a candy bar is the kind of counterintuitive finding that could reshape how we think about processed food—not as the enemy of health, but as a tool for it.

Subject of Research: Effects of extrusion cooking on postprandial glucose, insulin, and triglyceride responses to chocolate in healthy men

Article Title: Chocolate Processed by Extrusion Cooking Affects Glucose and Lipid Metabolism in Humans: A Randomized, Double‐Blind, Crossover Trial

Article References: Kinta, Y., Maruki‐Uchida, H., Umehara, M., Ito, R., Shiga, R., Yasumoto, Y., Mori, S., & Koikeda, T. (2026). Chocolate Processed by Extrusion Cooking Affects Glucose and Lipid Metabolism in Humans: A Randomized, Double‐Blind, Crossover Trial. Food Science & Nutrition, 14(10), Article e72409. https://doi.org/10.1002/fsn3.72409

Image Credits: AI Generated

DOI: 10.1002/fsn3.72409

Keywords: extrusion cooking, chocolate, postprandial metabolism, blood glucose, insulin, triglycerides, food processing, sugar dissolution, randomized crossover trial, food well-being, glycemic response, food structure